BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11362333)

  • 1. Protease inhibitor consensus statement.
    AIDS Treat News; 1995 Mar; (no 219):7. PubMed ID: 11362333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus statement on the further development of protease inhibitors and human growth hormone.
    AIDS Treat News; 1996 Mar; (no 243):8. PubMed ID: 11363302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA evaluates accelerated approval process. Food and Drug Administration.
    Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS task force grapples with faster access to protease drugs.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Mar; 1(2):6-11. PubMed ID: 11362314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitors: no knockout blow, but could be the best punch yet.
    AIDS Alert; 1996 Apr; 11(4):37-9. PubMed ID: 11363400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ritonavir, Abbott protease inhibitor, approved.
    AIDS Treat News; 1996 Mar; (no 243):2-3. PubMed ID: 11363300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitor approvals: will people be cut off drug? Followup studies proposal needs support.
    James JS
    AIDS Treat News; 1996 Mar; (no 242):3. PubMed ID: 11363191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More clinical data on protease inhibitors.
    Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):4-7. PubMed ID: 11362917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded access program for ABT-378 under way.
    Slovick J
    Posit Living; 1999 Nov; 8(10):10. PubMed ID: 11367322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What you need to know about protease inhibitors.
    AIDS Alert; 1996 Apr; 11(4):suppl 1-2. PubMed ID: 11363407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drug approved to treat HIV.
    Treat Rev; 1997 Apr; (No 24):5. PubMed ID: 11364284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nelfinavir: fourth protease inhibitor approved.
    Crit Path AIDS Proj; 1997; (No 32):31-2. PubMed ID: 11364442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rolling uncertainties of antiprotease prescribing.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 Feb; 2(2):6-10. PubMed ID: 11363341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitors: resistance, resistance, resistance.
    Gilden D; Falkenberg J; Torres G
    GMHC Treat Issues; 1997 Feb; 11(2):5-10. PubMed ID: 11364108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New treatments for HIV].
    Garcia E
    Sidahora; 1996; ():48-50. PubMed ID: 11363630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amprenavir, new protease inhibitor, approved.
    James JS
    AIDS Treat News; 1999 May; (No 318):1-3. PubMed ID: 11366454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICAAC: new drugs in late breaker session.
    James JS
    AIDS Treat News; 1999 Oct; (No 328):3-5. PubMed ID: 11366817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saquinavir gets accelerated approval.
    McGuire S
    Posit Aware; 1996; 7(1):8. PubMed ID: 11363135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indinavir (Crixivan), Merck protease inhibitor, approved.
    James JS
    AIDS Treat News; 1996 Mar; (no 243):1-2. PubMed ID: 11363299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whatever happened to expanded access?
    Notes Undergr; 1997; (No 35):2-3. PubMed ID: 11364564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.